Arsenic Exposure Reduction and Chronic Disease Mortality
JAMA · 2025
DOI: 10.1001/jama.2025.19161 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, 2025. Verfasst von Fen Wu und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Health, New York University Grossman School of Medicine, New York. Hauptthemen laut MEDLINE: Arsenic, Cardiovascular Diseases, Drinking Water, Environmental Exposure. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS.
Abstract (Originalsprache)
Importance Chronic exposure to arsenic in drinking water has been associated with increased chronic disease mortality. However, there is limited evidence on associations between reduced exposure and mortality risk.
Objective
To examine whether reductions in arsenic exposure, measured using urinary arsenic levels, are associated with lower mortality from chronic diseases, including cancer and cardiovascular disease (CVD). Design, Setting, and Participants A prospective cohort of 11 746 adults was enrolled between 2000 and 2002 in Araihazar, Bangladesh, with levels of well-water arsenic ranging from less than 1 µg/L to 864 µg/L (mean, 102 µg/L), exceeding the Bangladesh standard of 50 µg/L. Arsenic levels declined over time as a result of community mitigation. Mortality was tracked through 2022. Analyses included 10 977 participants with calculable changes in urinary arsenic levels. Exposures Urinary arsenic levels were measured up to 5 times per participant through 2018. Participants were categorized based on changes in urinary arsenic levels. Main Outcomes and Measures Adjusted hazard ratios (aHRs) and 95% CIs for mortality from chronic diseases, including cancer and CVD.
Results
Among 10 977 participants (57% female; mean age, 37.0 [SD, 10.1] years), mean urinary arsenic levels declined from 283 (SD, 314) to 132 (SD, 161) µg/g creatinine from 2000 to 2018. Each IQR decrease in urinary arsenic (197 µg/g creatinine) was associated with 22% lower chronic disease mortality (aHR, 0.78 [95% CI, 0.75-0.82]), 20% lower cancer mortality (aHR, 0.80 [95% CI, 0.73-0.87]), and 23% lower CVD mortality (aHR, 0.77 [95% CI, 0.73-0.81]). Time-varying Cox and restricted cubic spline analyses showed larger reductions were associated with lower mortality, while increases were linked to higher risk. Compared with participants with consistently high urinary arsenic levels (above the baseline median of 199 µg/g creatinine [n = 1757]), those whose levels declined below the median (n = 3757) had lower mortality from chronic diseases (aHR, 0.46 [95% CI, 0.39-0.53]), including cancer (aHR, 0.51 [95% CI, 0.35-0.73]) and CVD (aHR, 0.43 [95% CI, 0.34-0.53]), similar to those consistently below the median (n = 4959) (aHR, 0.43-0.49). Findings were similar in propensity score–matched analyses. Conclusions and Relevance These findings support an association between reduced arsenic exposure and improved health outcomes in populations exposed to contaminated drinking water.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Population Health, New York University Grossman School of Medicine, New York.
- Lamont-Doherty Earth Observatory of Columbia University, Palisades, New York.
- Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, New York.
- Department of Geology, University of Dhaka, Dhaka, Bangladesh.
- Boston University School of Public Health, Boston, Massachusetts.
- University of Chicago and Columbia University Research Project Office, Dhaka, Bangladesh.
Förderung
- NIEHS NIH HHS
Zitieren
APA
Wu, F., van Geen, A., Graziano, J., Ahmed, K. M., Liu, M., Argos, M., Parvez, F., Choudhury, I., Slavkovich, V. N., Ellis, T., Islam, T., Ahmed, A., Kibriya, M. G., Jasmine, F., Shahriar, M. H., Hasan, R., Shima, S. A., Sarwar, G., Navas-Acien, A., …, & Chen, Y. (2025). Arsenic Exposure Reduction and Chronic Disease Mortality. JAMA. https://doi.org/10.1001/jama.2025.19161
Vancouver
Wu F, van Geen A, Graziano J, Ahmed KM, Liu M, Argos M, et al. Arsenic Exposure Reduction and Chronic Disease Mortality. JAMA. 2025. doi:10.1001/jama.2025.19161
BibTeX
@article{Wu2025,
author = {Wu, Fen and van Geen, Alexander and Graziano, Joseph and Ahmed, Kazi Matin and Liu, Mengling and Argos, Maria and Parvez, Faruque and Choudhury, Imtiaz and Slavkovich, Vesna N and Ellis, Tyler and Islam, Tariqul and Ahmed, Alauddin and Kibriya, Muhammad G and Jasmine, Farzana and Shahriar, Mohammad Hasan and Hasan, Rabiul and Shima, Salma Akter and Sarwar, Golam and Navas-Acien, Ana and Ahsan, Habibul and Chen, Yu},
title = {Arsenic Exposure Reduction and Chronic Disease Mortality},
journal = {JAMA},
year = {2025},
doi = {10.1001/jama.2025.19161}
}
EUVIMED